Ovid Therapeutics, Inc. (OVID)
2.97
+0.18
(+6.45%)
USD |
NASDAQ |
Apr 14, 16:00
2.97
0.00 (0.00%)
After-Hours: 19:49
Ovid Therapeutics Cash from Investing (TTM) : -49.85M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| PTC Therapeutics, Inc. | -861.98M |
| CytomX Therapeutics, Inc. | -59.74M |
| Artelo Biosciences, Inc. | -0.0639M |
| Eton Pharmaceuticals, Inc. | -0.333M |
| ACADIA Pharmaceuticals, Inc. | -302.56M |